title: From risk reduction to implementation: Addressing the opioid epidemic and continued challenges to our field.
authors.affiliation: a Institute for Health Research, Kaiser Permanente Colorado , Denver , Colorado , USA.|b University of Colorado School of Medicine , Aurora , Colorado , USA.
authors.forename: Ingrid A
authors.initials: IA
authors.lastname: Binswanger
authors.affiliation: c University of Pittsburgh School of Medicine , Pittsburgh , Pennsylvania , USA.|d VA Pittsburgh Healthcare System , Pittsburgh , Pennsylvania , USA.
authors.forename: Adam J
authors.initials: AJ
authors.lastname: Gordon
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects* / Q000627:therapeutic use*; D062787:Drug Overdose / Q000188:drug therapy* / Q000453:epidemiology; D004501:Education, Medical; D006801:Humans; D009270:Naloxone / Q000627:therapeutic use; D009293:Opioid-Related Disorders / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control / Q000628:therapy*; D010146:Pain / Q000188:drug therapy; D040242:Risk Reduction Behavior; D014481:United States / Q000453:epidemiology
chemical_list: D000701:Analgesics, Opioid; D009270:Naloxone